Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX®
This study has been terminated.
( Slow recruitment; Study did not address safety concern raised by European Medicines Agency )
Study NCT00034788   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: May 2, 2002   Last Updated: July 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Foot Ulcer
Diabetic Foot
Skin Ulcer
Diabetic Neuropathies
Additional conditions recognized in this trial
Ulcer
More general conditions related to this trial
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Diabetic Angiopathies
Endocrine System Diseases
Foot Diseases
Leg Ulcer
Nervous System Diseases
Neuromuscular Diseases
Pathologic Processes
Peripheral Nervous System Diseases
Skin Diseases
Vascular Diseases
Interventions listed in this trial
Becaplermin
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services